ANSM (France) Inspections in both materiovigilance and pharmacovigilance.
|
|
- Charles Price
- 6 years ago
- Views:
Transcription
1 Curriculum vitae PERSONAL INFORMATION Olivier Diby WORK EXPERIENCE November 2015 Present Inspector Inspections in both materiovigilance and pharmacovigilance. November 2009 November 2015 MD, Drug Safety Officer BBAC sas (France) Pharmacovigilance, Materiovigilance, Nutrivigilance and Medical information Physician. - Management of a team of 4 drug safety officers, - Managing medical information inqueries, Pharmacovigilance, nutrivigilance and materiovigilance case reports in accordance with regulations and laws in force - Writing case narratives and company comments in both French and English, writing Periodic Safety Update Reports, writing Field Ssafety Corrective Action reports, writing Variations reports about human medicinal product, writing Addendum, Summary and Signal reports, - Making assessment of ADRs based on WHO causality assessment, Naranjo and the French causality assessment, - Editing CIOMS-I, line listing (CIOMS II), Summary Tabulation and xml files, - Weekly literature monitoring in French and international medical database (Medline, Embase and Reactions weekly), - Coding medical clinical data (from spontaneous reports and clinical trials) by MedDRA dictionary, - Quality control of clinical data and case narratives entered in the safety database «Safety-Easy», - Submitting cases to the competent authorities, including reporting of the cases by EudraVigilance web site, - Making Medical review, - Participating to internal and external audits, - Participating to the French Regulatory Agency inspections. February 2008 November 2009 MD, Drug Safety Officer ANTICIPSANTE (France) Pharmacovigilance, Materiovigilance, Nutrivigilance and Medical information Physician. - Managing medical information inqueries, Pharmacovigilance, nutrivigilance and materiovigilance case reports in accordance with regulations and laws in force, - Writing case narratives and company comments in both French and English, writing Periodic Safety Update Reports, writing Field Ssafety Corrective Action reports, writing Variations reports about human medicinal product, writing Addendum, Summary and Signal reports, - Making assessment of ADRs based on WHO causality assessment, Naranjo and the French causality assessment, - Editing CIOMS-I, line listing (CIOMS II), Summary Tabulation and xml files, - Weekly literature monitoring in French and international medical database (Medline, Embase and Reactions weekly), - Coding medical clinical data (from spontaneous reports and clinical trials) by MedDRA dictionary, - Quality control of clinical data and case narratives entered in the safety database «Safety-Easy», - Submitting cases to the competent authorities, including reporting of the cases by EudraVigilance web site, - Making Medical review, 19/2/18 European Union, Page 1 / 5
2 - Participating to internal and external audits, - Participating to the French Regulatory Agency inspections. January 2007 November 2007 MD, Medical data coder PHARMAPPEL (France) - Coding of medical clinical data received from clinical trials, from various therapeutic areas (by MedDRA dictionary, MedDRA Points to Consider, Who Drug Dictionary Enhanced), - Writing coding convention - Editing coded data homogeneization listing, - Making quality control and medical validation and writing coding reports. - Trainer to medical clincal data coding received from clinical trials by using MedDRA and Who Drug dictionaries. January 2005 January 2007 MD, Data Manager UMANIS (France) - Coding of medical clinical data received from clinical trials, from various therapeutic areas (by MedDRA dictionary, MedDRA Points to Consider, Who Drug Dictionary Enhanced), - Writing coding convention - Editing coded data homogeneization listing, - Making quality control and medical validation and writing coding reports. - Paper CRF and ecrf annotation, - Database creation (Clintrial 4.3 client interface and Cleanweb server interface), - Data entry tests and guide, - Database export from CT4.3 to SAS, from SAS/MACRO EXPORT to EXCEL, - Programming SAS Base1, SQL request (SQL PLUS), Database quality control, - Participating to the development of Cleanweb (a clinical research e-crf database). - My suggestions were taken into account by Uppsala Monitoring Centre in 2005, to correct ATC code coding error that I found in the Who Drug dictionary. January 2002 January 2005 Internal medicine Hopital Maison Blanche and Centre Hospitalier de Lagny (France) Care monitoring in geriatry and psychiatry Hospital. January 2000 January 2002 Internal Medicine AGENA (France) Care monitoring in geriatry. January 1999 January 2000 Internal Medicine Hopital Maison Blanche and Centre Hospitalier de Lagny (France) Care monitoring in geriatry and psychiatry Hospital. 19/2/18 European Union, Page 2 / 5
3 EDUCATION AND TRAINING January 2017 February 2017 Inspection of quality risk management: level 2 AFNOR (France) December 2016 December 2016 Analysis of causality in the context of the inspection and risk analysis in the context of the evaluation NEERIA (France) October 2016 October 2016 PhV Inspectors Working Group Training course / European Regulation on amendments to marketing authorization EMA / September 2016 September 2016 Relational dimensions of the inspection / Administrative follow-up of inspections EHESP / June 2016 June 2016 Data integrity in pharmaceutical industry May 2016 May 2016 Penal law / Pharmacovigilance March 2016 March 2016 MedDRA Coding MSSO (France) Training to MedDRA dictionary including safety data coding and SMQ use. - My suggestions will be taken into account by MSSO (in the september release), to correct a coding error that I find in the current version of this dictionary. June 2015 June 2015 My ereport and evereport database administration evedrug (France) Training to My ereport and evereport. March 2014 March 2014 SafetyEasy Advanced Application administration ABCUBE (France) Training to SafetyEasy Advanced Application (Pharmacovigilance database) October 2013 June 2014 University Diploma of Quality Auditor in Pharmaceutical industry Graduated Quality Auditor for auditing. Prepare, conduct and follow-up of audit. Clinical audit, pharmacovigilance audit, Investigator site audit, pharmaceutical company audit, subsidiary and supplier audit, CRO and CSO audit, Computerised systems validation audit (in production and under development), based on Regulatory frameworks and laws in force. 19/2/18 European Union, Page 3 / 5
4 November 2012 November 2012 Materiovigilance skills Seminar / Training: Evolution of the regulation of medical device. October 2012 October 2012 Auditing and inspecting skills Seminar / Training: Audit and Inspection in Pharmacovigilance. May 2011 May 2011 EudraVigilance Medicinal Product data entry skills DIA (France) Training to EVMPD (EudraVigilance Medicinal Product Dictionary) March 2009 March 2009 Monitoring pharmacovigilance adverse effects skills IFIS (France) Training to monitoring pharmacovigilance adverse effects in the literature. November 2007 December 2007 Pharmacovigilance officer For Drug Consulting (France) Pharmacovigilance Physician training. February 2005 February 2005 Medical coder UMANIS (France) Medical Clinical Data Coding Training. September 2004 December 2004 DATA MANAGER SUPSANTE Paris (France) Health Data Manager Professional Training. September 2002 June 2003 European master II Paris V Faculty of Biomedical (France) European Master specialized in health and safety in transport; air transport option. Trainee at Air France and Paris Roissy and Orly Airports. Theme: co-activity. Risk prevention plan performed. September 2001 June 2002 University Diploma in Emergency Medical Help Paris V Faculty of Medicine & Emergency Medical Unit of Paris (France) Emergency Medical Help. September 2000 June 2001 Gerontology skills CNED (France) Training in Gerontology. September 1999 June 2000 Biostatistics skills Paris XI University (France) Training in Biostatistics. 19/2/18 European Union, Page 4 / 5
5 September 1989 June 1998 Medicine Doctor Faculty of Health Science of Cotonou (Benin) Graduated in human médicine. Certificate of post-doctoral education, issued by the Academy of Creteil (France). Certificate of scientific equivalence to the French Doctorate in Medicine, issued by the French Minister of National Education. ADDITIONAL INFORMATION Expertise Publications Projects Memberships Other Relevant Information 19/2/18 European Union, Page 5 / 5
Data retrieval using the new SMQ Medication Errors
Data retrieval using the new SMQ Medication Errors Christina Winter Medical Director Safety Evaluation and Risk Management, GSK Information Day on Medication Errors 20 October 2016 London, UK Disclaimer
More informationCurriculum Vitae. Lone Cleveland Andersen. Courses
Courses and continuing education, listed by subjects. GMP courses API Curriculum Vitae Lone Cleveland Andersen Courses ICH Q7; Compliance for API s manufactured by cell culturing and fermentation, European
More informationHolders of European Union marketing authorizations
PRAC Experience The legal framework The Pharmacovigilance legislation (Regulation No 1235/2010 and Directive 2010/84/EU) was adopted by the European Parliament and European Council in December 2010. The
More informationAGREEMENT ON COMMON PRINCIPLES AND RULES OF CIRCULATION OF MEDICINAL PRODUCTS WITHIN THE EURASIAN ECONOMIC UNION. (Moscow, 23 December 2014)
AGREEMENT ON COMMON PRINCIPLES AND RULES OF CIRCULATION OF MEDICINAL PRODUCTS WITHIN THE EURASIAN ECONOMIC UNION (Moscow, 23 December 2014) Member States of the Eurasian Economic Union, hereinafter referred
More informationIII Edition May November 2014 Siena, Italy. Master Program in Vaccinology and Pharmaceutical Clinical Development
III Edition May 2013 - November 2014 Siena, Italy Master Program in Vaccinology and Pharmaceutical Clinical Development Index Sponsors 3 Technical-Scientific Committee 4 Organization, Venue and Duration
More informationREPUBLIC OF KENYA MINISTRY OF MEDICAL SERVICES PHARMACY AND POISONS BOARD
REPUBLIC OF KENYA MINISTRY OF MEDICAL SERVICES PHARMACY AND POISONS BOARD Ensuring the provision of quality, safe and efficacious pharmaceutical products and services. FUNCTIONS OF THE BOARD BACKGROUND
More informationAIFA UNICRI FDA TRAINING COURSE. on GCP Inspectorates and GCP Inspections
AIFA UNICRI FDA TRAINING COURSE on GCP Inspectorates and GCP Inspections Civil Service Training Centre (CSTC) P.O.Box M49, Cantonments, Accra, Ghana 7-11 July 2014 AGENDA Monday 7 July 2014 8.30 9.00 Registration
More information(Legislative acts) REGULATIONS
31.12.2010 Official Journal of the European Union L 348/1 I (Legislative acts) REGULATIONS REGULATION (EU) No 1235/2010 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 15 December 2010 amending, as regards
More informationRegulatory Aspects of Pharmacovigilance
Regulatory Aspects of Pharmacovigilance Deirdre Mc Carthy Pia Caduff-Janosa Training Course Uppsala 2013 Agenda Risk based approach to spontaneous reporting (incl clinical trials) -> Pia Caduff-Janosa
More informationATMPs & EU GMP Update. Bryan J Wright July 2017
ATMPs & EU GMP Update Bryan J Wright July 2017 Slide 1 PharmOut 2017 Outline ATMPs What they are? Why are we looking at this subject? The Licensing position of ATMPs and use of PRIME ATMPs and GMP Inspections
More informationMedical Writing in Pharmacovigilance. Update your English writing skills in this course - with many exercises!
Medical Writing in Pharmacovigilance Update your English writing skills in this course - with many exercises! FORUM Institut für Management GmbH Programme Overview of contents Key pharmacovigilance definitions
More informationGERIATRIC TEACHING AND TRAINING IN EUROPE: Where are we? (part I)
GERIATRIC TEACHING AND TRAINING IN EUROPE: Where are we? (part I) Pr. Olivier Beauchet, MD, PhD Department of Neuroscience Geriatrics Division and Memory Clinic Angers University Hospital and School of
More information3-Year Academic Assessment Plan Cover Sheet Assessment plans are due February 16, to:
Program Information: 3-Year Academic Assessment Plan Cover Sheet Assessment plans are due February 16, 2015 Email to: assessment@unlv.edu Office of Academic Assessment Program Assessed Department College
More informationThe Committee for Medicinal Products for Human Use
www.eurordis.org The Committee for Medicinal Products for Human Use Patrick Salmon IMB Barcelona, 20 June, 2013 2 EURORDIS SUMMER SCHOOL 2013 CHMP CHMP... What is it? 3 EURORDIS SUMMER SCHOOL 2013 CHMP
More informationCOMMISSION OF THE EUROPEAN COMMUNITIES. Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL
EN EN EN COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 10.12.2008 COM(2008) 664 final 2008/0257 (COD) Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL amending, as regards pharmacovigilance
More informationINDEPENDANT CONSULTING FOR QUALITY AND REGULATORY AFFAIRS EXPERTS FOR MEDICAL DEVICES REFERENCES. DATE POSITION ACTIVITIES MEDICAL DEVICES 2009 to NOW
INDEPENDANT CONSULTING FOR QUALITY AND EXPERTS FOR MEDICAL DEVICES REFERENCES OUTSOURCED SERVICES DATE POSITION ACTIVITIES MEDICAL DEVICES 2009 to NOW QUALITY AND MANAGER company which designs and manufactures
More information2008 Public Status Report on the Implementation of the European Risk Management Strategy. Executive Summary
European Medicines Agency London, 17 March 2009 Doc. Ref. EMEA/43556/2009 2008 Status Report on the Implementation of the European Risk Management Strategy Executive Summary The European Risk Management
More informationMedication Errors a challenge of pharmacovigilance BfArM experience
Medication Errors a challenge of pharmacovigilance BfArM experience Dr. Claudia Kayser Federal Institute for Drugs and Medical Devices Medication safety / Pharmacovigilance 1 Disclosure Statement X I have
More informationClinical Trials in Third Countries
Clinical Trials in Third Countries meeting, 29 January 2015 Presented by Fergus Sweeney European Medicines Agency An agency of the European Union Overview Distribution of clinical trials submitted in support
More informationCosts and Limitations
Costs and Limitations For Certified Healthcare IT EHR EMR Version 10.0 07/14/2017 Penn Medical Informatics Systems, Inc Costs and Limitations for EyeDoc EMR Version 10.0 Capability and Description 2014
More informationTransparenzvorgaben in der Klinischen Prüfung
Transparenzvorgaben in der Klinischen Prüfung Dr. Stefan Strasser Institut Überwachung, Abteilung Klinische Prüfung stefan.strasser@ages.at AGES Gespräch 29.10.2015 Bundesamt für Sicherheit im Gesundheitswesen,
More informationDecentralised Procedure. Public Assessment Report. Budesonid Sandoz 32 / 64 Mikrogramm/Sprühstoß Nasenspray, Suspension.
Decentralised Procedure Public Assessment Report Budesonid Sandoz 32 / 64 Mikrogramm/Sprühstoß Nasenspray, Suspension Budesonide DE/H/0933/001-002/DC Applicant: Sandoz Pharmaceuticals GmbH Reference Member
More informationMedication errors. Impact of medication error guidance and regulation on drug-device combination products. June 2017 Dan Wozinski
Medication errors Impact of medication error guidance and regulation on drug-device combination products June 2017 Dan Wozinski Agenda Understand the management of medication errors within global requirements
More informationOther EU Activities Contributing to Harmonization of Labeling
Other EU Activities Contributing to Harmonization of Labeling Dr Laurent Brassart European Medicines Agency Medical Information Sector DIA Labeling Harmonisation 2011 Workshop October 13-14. 2011 Disclaimer
More informationFaculty of Social Sciences
Faculty of Social Sciences Programme Specification Programme title: MSc Psychology Academic Year: 2017/18 Degree Awarding Body: Partner(s), delivery organisation or support provider (if appropriate): Final
More informationWyss Zürich Regulatory Affairs Seminar
Wyss Zürich Regulatory Affairs Seminar Hospital Exemption & Compassionate Use EU Framework Catherine Longeval Koen T Syen Zürich, 5 July 2017 1 Table of contents Introduction Hospital Exemption Implementation
More informationThe Committee for Medicinal Products for Human Use
www.eurordis.org The Committee for Medicinal Products for Human Use Patrick Salmon HPRA Barcelona, 4th June, 2015 2 CHMP 3 CHMP Move 4 The New CHMP 5 Where it all happens! 6 CHMP... What is it? CHMP What
More informationKurse Epidemiology & Public Health
Der Titel des PDFs ist in der Localize-Variable title_pdf_standard abgelegt. Manuelle Zeilenumbrüche können mit dem Pipe-Symbol gesetzt werden. Kurse Epidemiology & Public Health Coordinator: Mrs. Catherine
More informationGuideline on good pharmacovigilance practices (GVP)
19 April 2013 EMA/169546/2012 Guideline on good pharmacovigilance practices (GVP) Module X Additional monitoring Draft finalised by the Agency in collaboration with Member States 25 May 2012 Draft agreed
More informationLEAF Marque Assurance Programme
Invisible ISEAL Code It is important that the integrity of the LEAF Marque Standard is upheld therefore the LEAF Marque Standards System has an Assurance Programme to ensure this. This document outlines
More informationSession 2. Data analysis based on overview of EudraVigilance data. Victoria Newbould, EMA, EU. Medication-errors workshop London, 20 October 2016
Session 2 Data analysis based on overview of EudraVigilance data Victoria Newbould, EMA, EU Medication-errors workshop London, 20 October 2016 An agency of the European Union Acknowledgement Steven Le
More informationCOACHING, CLIENTS AND COMPETENCIES: How Coaches Experience the Flow State. Barrett W. McBride, PhD. Summary of Research Findings
COACHING, CLIENTS AND COMPETENCIES: How Coaches Experience the Flow State Barrett W. McBride, PhD Summary of Research Findings 2013, 2016 Barrett W. McBride Reproduction with Attribution Permitted INTRODUCTION
More informationGlobal Pediatric Development: We Are Making Progress. PMDA Perspective. Junko Sato, PhD PMDA
Global Pediatric Development: We Are Making Progress PMDA Perspective Junko Sato, PhD PMDA Disclaimer The views and opinions expressed in the following PowerPoint slides are those of the individual presenter
More informationCHAPTER 4 POST-MARKETING SURVEILLANCE OF DRUGS
CHAPTER 4 POST-MARKETING SURVEILLANCE OF DRUGS Post-marketing surveillance (PMS) to assure the quality, efficacy and safety of drugs after they go on the market and to establish proper methods of use of
More informationPROGRAMMER S SAFETY KIT: Important Points to Remember While Programming or Validating Safety Tables
PharmaSUG 2012 - Paper IB09 PROGRAMMER S SAFETY KIT: Important Points to Remember While Programming or Validating Safety Tables Sneha Sarmukadam, Statistical Programmer, PharmaNet/i3, Pune, India Sandeep
More informationKEY DIFFERENCES BETWEEN THE NEW MEDICAL DEVICE AND THE OTC REGULATIONS IN EUROPE
RNI Conseil 2017 Tous droits réservés Toute reproduction interdite sans l'autorisation de l'auteur. KEY DIFFERENCES BETWEEN THE NEW MEDICAL DEVICE AND THE OTC REGULATIONS IN EUROPE Anne Laure TARDY, PhD
More informationSAS 112: Communicating Internal Control Related Matters Identified in an Audit
SAS 112: Communicating Internal Control Related Matters Identified in an Audit Effective: NOW!!! For audits of financial statements for periods ending on or after December 15, 2006. SAS 112 Requires the
More informationEducation. Current Activities
Nirali Mehta, M.Sc., M.Phil. Founder & Consultant Biostatistician Ahmedabad, Gujarat, India. M +91 9377060504 E nirali.mehta@pharma-stats.in W www.pharma-stats.in Education 1998-2001 Bachelor of Science
More informationquality and safety of pharmacy preparations in Europe
quality and safety of pharmacy preparations in Europe Henk Scheepers, Pharm D, Senior-Inspector Public Health Supervisory Service Health Care Inspectorate The Netherlands 1 Nothing to disclose 2 1 quality
More informationPharmacovigilance Working Party (PhVWP)
29 July 2010 EMA/455361/2010 Patient Health Protection Monthly report Issue number: 1007 Pharmacovigilance Working Party (PhVWP) July 2010 plenary meeting The CHMP Pharmacovigilance Working Party (PhVWP)
More informationPreview of New MedDRA Hierarchy for Medication Errors Coding and Retrieval Considerations
Preview of New MedDRA Hierarchy for Medication Errors Coding and Retrieval Considerations Judy Harrison, M.D. Chief Medical Officer MedDRA MSSO Information Day on Medication Errors 20 October 2016 London,
More informationNDT Training & Consulting
NDT Training & Consulting Authorized Independent Outside Agency (AIOA) Level III Services www.hellierndt.com Level Ill Technical Support Development of NDT Written Practices NDT Procedures & Techniques
More informationPHOTO. VHPB/ELPA MEETING Prevention and Control of Viral Hepatitis The role and impact of patients and advocacy groups in and outside Europe
www.eurordis.org VHPB/ELPA MEETING Prevention and Control of Viral Hepatitis The role and impact of patients and advocacy groups in and outside Europe Lucca ( Italy ) March 13-14, 2008 PHOTO www.eurordis.org
More informationOverview of methodologies and studies evaluating risk minimisation measures
Overview of methodologies and studies evaluating risk minimisation measures Giampiero Mazzaglia MD, PhD Scientific and Regulatory Management Department EMA 16 September 2015 An agency of the European Union
More informationUpdate regarding PSUR and RMP for herbal and homeopathical medicinal products
Update regarding PSUR and RMP for herbal and homeopathical medicinal products Mag. Dr. Irmgard Resch Dept. Pharmacovigilance AGES-Gespräche 11.11.2014 www.basg.gv.at Österreichische Agentur für Gesundheit
More informationADVANCED COURSE IN PRE-CLINICAL AND CLINICAL RESEARCH
ADVANCED COURSE IN PRE-CLINICAL AND CLINICAL RESEARCH Academic year 2018-2019 COORDINATOR Prof. Susanna Esposito Full Professor of Pediatrics Department of Surgical and Biomedical Sciences Italy SCHOOL
More informationQ&A on Off-Label Use. EMA Industry Stakeholder Platform - Operation of EU Pharmacovigilance Legislation 12 January 2015
Proposal in response to EFPIA paper of 3 rd October 2014 EMA Industry Stakeholder Platform - Operation of EU Pharmacovigilance Legislation 12 January 2015 Presented by Sabine Brosch (EMA) and Anja van
More informationCOMMITTEE OF EXPERTS ON THE CLASSIFICATION OF MEDICINES AS REGARDS THEIR SUPPLY (CD-P-PH/PHO) PROGRAMME RESULTS
COMMITTEE OF EXPERTS ON THE CLASSIFICATION OF MEDICINES AS REGARDS THEIR SUPPLY (CD-P-PH/PHO) PROGRAMME RESULTS 2016-2017 Introduction This summary provides an overview of the activities carried out by
More informationRegulation of Herbal and Traditional Medicines in Germany BfArM in Dialogue - TradReg 2017
Regulation of Herbal and Traditional Medicines in Germany BfArM in Dialogue - TradReg 2017 Prof. Dr. Werner Knöss, Dr. Jacqueline Wiesner TradReg2017 Germany September 2017 Page 1 Federal Institute for
More informationREPUBLIC OF KENYA MINISTRY OF HEALTH PHARMACY AND POISONS BOARD DRAFT GUIDELINE FOR IMPORTATION OF ORPHAN MEDICINAL SUBSTANCES IN KENYA
PPB/REG/TRA/GUD/003 REPUBLIC OF KENYA MINISTRY OF HEALTH PHARMACY AND POISONS BOARD DRAFT GUIDELINE FOR IMPORTATION OF ORPHAN MEDICINAL SUBSTANCES IN KENYA September 2015, Version 1 P.O. BOX 27663, LENANA
More informationClinicalTrials.gov a programmer s perspective
PhUSE 2009, Basel ClinicalTrials.gov a programmer s perspective Ralf Minkenberg Boehringer Ingelheim Pharma GmbH & Co. KG PhUSE 2009, Basel 1 Agenda ClinicalTrials.gov Basic Results disclosure Initial
More informationTerminologies for recording of ADR:s
Terminologies for recording of ADR:s 1 Adverse reaction terms? Dizziness SOB. feeling hot.? dyspnoea lightheadedness.? breath shortness. evidence of VEBS on 2 ECG Concepts Terminology collection of accepted
More informationJUEN14, EU Criminal Law, 15 credits EU-straffrätt, 15 högskolepoäng Second Cycle / Avancerad nivå
Faculty of Law JUEN14, EU Criminal Law, 15 credits EU-straffrätt, 15 högskolepoäng Second Cycle / Avancerad nivå Details of approval The syllabus was approved by Faculty of Law Board of education at undergraduate
More informationRegulatory Framework for Medical Devices in South Africa. 23 November 2018 Andrea Keyter Deputy Director: Medical Devices
Regulatory Framework for Medical Devices in South Africa 23 November 2018 Andrea Keyter Deputy Director: Medical Devices Medicines and Related Substances Act, 1965 (Act 101 of 1965) Act 72 of 2008 and
More informationGuide to Interchangeable Medicines
Guide to Interchangeable Medicines AUT-G0115-6 01 JUNE 2018 This guide does not purport to be an interpretation of law and/or regulations and is for guidance purposes only. CONTENTS 1 BACKGROUND 3 1.1
More informationRecommendations of fourth meeting of the WHO Advisory Committee on Safety of Medicinal Products 26 and 27 February 2007
Recommendations of fourth meeting of the WHO Advisory Committee on Safety of Medicinal Products 26 and 27 February 2007 The WHO Advisory Committee on Safety of Medicinal Products (ACSoMP) held its fourth
More informationActive TB drug-safety management & monitoring
Active TB drug-safety management & monitoring Global TB Programme, WHO, Switzerland 6 August 2015 Pharmacovigilance: definition of science and activities relating to the detection, assessment, understanding
More informationADVANCED MANUFACTURING CAREER CLUSTER
ADVANCED MANUFACTURING CAREER CLUSTER QUALITY ASSURANCE/ CONTROL PRODUCTION Industrial Production Managers MAINTENANCE AND REPAIR Research & Development/ Materials Industrial and Manufacturing Mechanical
More informationPoints to Consider CPhI Japan Briefing Session on Pharmaceutical Regulations in Japan
2013 CPhI Japan Briefing Session on Pharmaceutical Regulations in Japan The Master File System and Points to Consider Kentaro Hashimoto, Master File Management Group, Division of Pharmacopoeia and Standards
More informationPharmacovigilance in HIV/AIDS Public Health Programmes: Luxury or Priority?
Pharmacovigilance in HIV/AIDS Public Health Programmes: Luxury or Priority? Micheline Diepart WHO HIV/AIDS ATC Launching a Three-Year Initiative Developing pharmacovigilance (PV) for antiretroviral medicines
More informationMedDRA - International standard for coding safety information. The Golden Triangle
MedDRA - International standard for coding safety information International Pharmacovigilance Conference Moscow, Russia 10 October 2018 Anna Zhao-Wong, MD, PhD MedDRA MSSO The Golden Triangle (MedDRA)
More informationCURRICULUM VITAE. Date of birth July 30th, 1960 PERSONAL INFORMATIONS. Curriculum vitae of Alberto Matteelli pag. 1/6
E U R O PA S S CURRICULUM VITAE PERSONAL INFORMATIONS Surname/First name Alberto Matteelli Address Passirano (Brescia) Piazza Europa 24, ZIP 25050 Telephone (s) +39.030.3995802 (office) Mobile: +30.339.3344033
More informationPROVISIONAL TRANSLATION
- 3 - CROATIAN PARLIAMENT 1035 Pursuant to Article 88 of the Constitution of the Republic of Croatia, I hereby issue the DECISION PROMULGATING THE ACT ON AMENDMENTS TO THE MEDICINAL PRODUCTS ACT I hereby
More informationProcedure for Expedited Review of imported pre-qualified vaccines for use in national immunization programmes
Procedure for Expedited Review of imported pre-qualified vaccines for use in national immunization programmes Dr Nora Dellepiane/Dr Anil Kumar Chawla WHO/HQ-Geneva, Switzerland 1 Expedited review procedure
More informationGROCERY MANUFACTURERS ASSOCIATION. Science Forum. Connecting Sound Science and Responsible Solutions
GROCERY MANUFACTURERS ASSOCIATION Science Forum Connecting Sound Science and Responsible Solutions FSMA Implementation Michael M. Landa Director, Center for Food Safety and Applied Nutrition Food and Drug
More informationRoutine signal detection and statistical tools on paediatrics
Routine signal detection and statistical tools on paediatrics Paediatric workshop 28 April 2014 Presented by: Cosimo Zaccaria Signal Management Pharmacovigilance Department An agency of the European Union
More informationPracticum 3 Implementation and Integration PC 443 Description Practicum 3
Practicum 3 Implementation and Integration PC 443 Description Practicum 3 Practicum 3 is advanced supervised clinical experience during which the student integrates learning and achieves entry level skills
More informationCooperation between HALMED and GMP Inspectorate in supervision of manufacturers: Croatia s experience so far
Cooperation between HALMED and GMP Inspectorate in supervision of manufacturers: Croatia s experience so far Ana Boban, MPharm. Agency for Medicinal Product and Medical Devices of Croatia Dubrovnik, 06.05.2013.
More informationMASTER OF SCIENCE OCCUPATIONAL THERAPY
Page 1 6/16/2014 9:18 AM MASTER OF SCIENCE OCCUPATIONAL THERAPY Occupational therapy is the art and science of facilitating participation in occupations. The core concepts and knowledge base of occupational
More informationMasterclass on Clinical Research: How to design a clinical trial
Masterclass on Clinical Research: How to design a clinical trial DAY 1 (Tuesday, 5 March 2013) - Core skills for clinical research 09:30-10:30 Registration and Coffee 10:30 10:35 Welcome Rupert Pearse
More informationSAFETY OF MEDICINES: CLINICAL C TRIALS AND PHARMACOVIGILANCE. Robert Lindblad, M.D. Chief Medical Officer The EMMES Corporation
SAFETY OF MEDICINES: CLINICAL C TRIALS AND PHARMACOVIGILANCE Robert Lindblad, M.D. Chief Medical Officer The EMMES Corporation The Quality of Safety Data Sf Safety vs. efficacy Adverse event reporting
More information- The development of a training, qualifications and registration system for BSL / English Interpreters.
SUBJECT: INTERPRETING CONFERENCE SUPPORTING DEAF PEOPLE AN INTERNATIONAL ONLINE CONFERENCE FOR INTERPRETING PROFESSIONALS. THEMES: TRAINING, ETHICS AND PROFESSIONALISM AND EDUCATIONAL INTERPRETING. CACDP
More informationCURRICULUM VITAE. Maria Tcherni
CURRICULUM VITAE Maria Tcherni Work address: University at Albany, SUNY 135 Western Ave, Albany NY 12222 Home address: 2351 Algonquin Rd Niskayuna, NY 12309 Cell: (518) 366-1013 Email: tcherni@gmail.com
More informationGuideline on the processing of renewals in the centralised procedure
14 July 2016 Committee for Human Medicinal Products (CHMP) Guideline on the processing of renewals in the centralised procedure Transmission to CPMP November 2000 Release for consultation December 2000
More informationBlanka Hirschlerová. EDQM CEP conference Prague, Czech Republic
1 Experience with CEPs from a European regulatory authority perspective Blanka Hirschlerová EDQM CEP conference Prague, Czech Republic 2012 STATE INSTITUTE FOR DRUG CONTROL Agenda 2 Agenda Introduction
More information2010/SOM3/LSIF/032 LSIF Initiatives Medical Devices Global Regulatory Harmonization and Anti-Counterfeit Medicines Global Cooperation
2010/SOM3/LSIF/032 LSIF Initiatives Medical Devices Global Regulatory Harmonization and Anti-Counterfeit Medicines Global Cooperation Submitted by: United States Life Sciences Innovation Forum Sendai,
More informationProgramme Specification
Programme Specification and Curriculum Map for MSc Criminology with Forensic Psychology Programme Specification 1. Programme title MSc Criminology with Forensic Psychology 2. Awarding institution Middlesex
More informationPROGRAMME SPECIFICATION Final. MSc Physiotherapy and Education MSc Physiotherapy and Management
PROGRAMME SPECIFICATION Final PART 1: COURSE SUMMARY INFORMATION Course summary Final award Intermediate award Course status Awarding body School Location of study/ campus Partner institution(s) MSc Physiotherapy
More informationIAEA EXPERIENCE IN ISO ACCREDITATION OF WHOLE BODY COUNTER AS PART OF THE RADIATION MONITORING AND PROTECTION
PIANOLIB Workshop Gothenburg 15-16 September 2011 IAEA EXPERIENCE IN ISO 17025 ACCREDITATION OF WHOLE BODY COUNTER AS PART OF THE RADIATION MONITORING AND PROTECTION SERVICES. Rodolfo Cruz Suárez Radiation
More informationREGIONAL ALLIANCE FOR NATIONAL REGULATORY AUTHORITIES FOR VACCINES IN THE WESTERN PACIFIC. second edition
REGIONAL ALLIANCE FOR NATIONAL REGULATORY AUTHORITIES FOR VACCINES IN THE WESTERN PACIFIC second edition World Health Organization 2014 The designations employed and the presentation of the material in
More informationValidation Introduction. Presented by John Montalto 27 March, 2013
Validation Introduction Presented by John Montalto 27 March, 2013 John Montalto Bachelor of Science Management Diploma >15 years of Industry Experience Consultant to United Nations various Government Regulatory
More informationUniversity at Buffalo School of Public Health and Health Professions Department of Rehabilitation Science Doctor of Physical Therapy Program
University at Buffalo School of Public Health and Health Professions Department of Rehabilitation Science Doctor of Physical Therapy Program Course Number: PT 712 Course Title: Clinical Residency (Culminating
More informationStudents must meet the standard entry requirements as set in the University Regulations.
Programme Specification and Curriculum Map for Postgraduate Certificate (PG Cert) Postgraduate Diploma (PG Dip) Master of Science (MSc) Chinese Medicine 1. Programme title MSc/ PG Dip/PG Cert Chinese Medicine
More informationDrug Safety Monitoring in a Prepandemic and Pandemic Avian Flu Mass Vaccination Scenario
Drug Safety Monitoring in a Prepandemic and Pandemic Avian Flu Mass Vaccination Scenario Andres Schneider Head Vigilance Unit Swiss Agency for Therapeutic Products Background (1) The Swiss government has
More informationQuality Management System Certification. Understanding Quality Management System (QMS) certification
Quality Management System Certification Understanding Quality Management System (QMS) certification The medical device manufacturing sector is one of the most regulated sectors in which significant quality
More informationMedDRA Overview A Standardized Terminology
MedDRA Overview A Standardized Terminology Patrick Revelle Director, MedDRA MSSO 6 May 2010 MedDRA is a registered trademark of the International Federation of Pharmaceutical Manufacturers and Associations
More informationAutomatic extraction of adverse drug reaction terms from medical free text
Automatic extraction of adverse drug reaction terms from medical free text Ola Caster Uppsala Monitoring Centre WHO Collaborating Centre for International Drug Monitoring ISCB 2009, Prague, Czech Republic
More informationQuality, Safety and Sourcing in Unlicensed Medicines
Quality, Safety and Sourcing in Unlicensed Medicines with Andrew Trouton Managing Director, UL Medicines Agenda Welcome What is an unlicensed medicine? When should you consider using an unlicensed medicine?
More informationStandard Operating Procedures (SOP) Research and Development Office
Standard Operating Procedures (SOP) Research and Development Office Title of SOP: GCP Inspection Procedures (MHRA) SOP Number: 15 Version Number: 2.0 Supercedes: 1.0 Effective date: August 2013 Review
More informationBILATERAL SCREENING MEETING
Negotiating Group for the Accession of the Republic of Serbia to the European Union - Chapter 28, Consumer and Health Protection BILATERAL SCREENING MEETING Chapter 28 Consumer and Health Protection Brussels,
More informationThe NIH Biosketch. February 2016
The NIH Biosketch February 2016 Outline NIH Biosketch Instructions NCBI My Bibliography Tools for creating a biosketch Word Template NCBI SciENcv Rules NIH Biosketch Questions are Welcome... Unanswerable
More informationUpdate on the revision of the new package leaflet (PL) template. An agency of the European Union
Update on the revision of the new package leaflet (PL) template An agency of the European Union Contents Regulatory background New QRD package leaflet template -Origin - Contents and structure 2 Regulatory
More informationAll member States were represented, except Bulgaria and Czech Republic
SANCO D1(2007)D/412302 SUMMARY RECORD OF THE STANDING COMMITTEE ON THE FOOD CHAIN AND ANIMAL HEALTH HELD IN BRUSSELS ON 5 OCTOBER 2007 SECTION TOXICOLOGICAL SAFETY OF THE FOOD CHAIN President : Mrs Patricia
More informationPHTH 571, 572, 573 AND 620
COURSE OUTLINES FOR CLINICAL PRACTICUMS IN PHYSICAL THERAPY PHTH 571, 572, 573 AND 620 THE GENERAL LEARNING OUTCOMES REFER TO ALL FOUR CLINICAL PRACTICUMS. SPECIFIC LEARNING OUTCOMES THAT FOLLOW REFER
More informationCurriculum Vitae JULIE PRESENT KOLLER, B.A.
Curriculum Vitae JULIE PRESENT KOLLER, B.A. CONTACT INFORMATION 8 Rex Avenue, Unit 5 Philadelphia, PA 19118 (650) 996-1757 Julie.present@gmail.com EDUCATION 2009- Drexel University Philadelphia, PA Ph.D.
More informationThis is an unofficial English translation of the Royal Decree 1344/2007 revised by the Spanish Agency for Medicines and Medical Devices
agencia española de medicamentos y productos sanitarios This is an unofficial English translation of the Royal Decree 1344/2007 revised by the Spanish Agency for Medicines and Medical Devices ROYAL DECREE
More informationORDER of the Minister of Health No. 269/2017 of 14 March 2017 on mandatory provision of medicinal product adequate and continuous supplies
ORDER of the Minister of Health No. 269/2017 of 14 March 2017 on mandatory provision of medicinal product adequate and continuous supplies ISSUING BODY: The Ministry of Health published in: the Official
More informationPROPOSED REGULATION OF THE BOARD OF HEARING AID SPECIALISTS. LCB File No. R February 29, 2000
PROPOSED REGULATION OF THE BOARD OF HEARING AID SPECIALISTS LCB File No. R020-00 February 29, 2000 EXPLANATION Matter in italics is new; matter in brackets [omitted material] is material to be omitted.
More informationThe Training & Education Unit of F-CRIN's head office. Project manager
Develop and boost training in clinical research Train the actors of clinical research A training course offer built specificaly to answer both the needs of the professionals and the patients: professions,
More informationDr. Amira Alazab CV (Curriculum Vitae)
Dr. Amira Alazab CV (Curriculum Vitae) # Personal Details: Name : Amira Mohamed Khalil Ismail Alazab Date of birth : Oct., 1 st, 1984 Place of birth : Al Dakahlia - Egypt Work : Assistant Lecturer in Medical
More information